Elanix Biotechnologies AG (FRA:ELN) Scaled Net Operating Assets : -0.07 (As of Dec. 2018)

View and export this data going back to . Start your Free Trial

What is Elanix Biotechnologies AG Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Elanix Biotechnologies AG's operating assets for the quarter that ended in Dec. 2018 was €1.06 Mil. Elanix Biotechnologies AG's operating liabilities for the quarter that ended in Dec. 2018 was €2.48 Mil. Elanix Biotechnologies AG's Total Assets for the quarter that ended in Jun. 2018 was €21.57 Mil. Therefore, Elanix Biotechnologies AG's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2018 was -0.07.

Elanix Biotechnologies AG Scaled Net Operating Assets Historical Data

The historical data trend for Elanix Biotechnologies AG's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elanix Biotechnologies AG Scaled Net Operating Assets Chart

Elanix Biotechnologies AG Annual Data

Trend

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Scaled Net Operating Assets

Get a 7-Day Free Trial

1.34

50.97

0.68

0.02

-0.58

Elanix Biotechnologies AG Semi-Annual Data
	Dec08	Dec09	Jun10	Dec10	Jun11	Dec11	Jun12	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18
Scaled Net Operating Assets	Get a 7-Day Free Trial															0.70	0.73	0.01	6.15	-0.07

Competitive Comparison of Elanix Biotechnologies AG's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Elanix Biotechnologies AG's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Elanix Biotechnologies AG's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Elanix Biotechnologies AG's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Elanix Biotechnologies AG's Scaled Net Operating Assets falls into.

Elanix Biotechnologies AG Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Elanix Biotechnologies AG's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2018 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2018 )
=	(Operating Assets (A: Dec. 2018 )	-	Operating Liabilities (A: Dec. 2018 ))	/	Total Assets (A: Dec. 2017 )
=	(1.058	-	2.48)	/	2.466
=	-0.58

where

	Operating Assets		(A: Dec. 2018 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	1.078	-	0.02
=	1.058

	Operating Liabilities		(A: Dec. 2018 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	2.48	-	0	-	0
=	2.48

Elanix Biotechnologies AG's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2018 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Dec. 2018 )
=	(Operating Assets (Q: Dec. 2018 )	-	Operating Liabilities (Q: Dec. 2018 ))	/	Total Assets (Q: Jun. 2018 )
=	(1.058	-	2.48)	/	21.569
=	-0.07

where

	Operating Assets		(Q: Dec. 2018 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	1.078	-	0.02
=	1.058

	Operating Liabilities		(Q: Dec. 2018 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	2.48	-	0	-	0
=	2.48

Elanix Biotechnologies AG Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Elanix Biotechnologies AG's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Elanix Biotechnologies AG (FRA:ELN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Elanix Biotechnologies AG (FRA:ELN) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

Street-4, Georg-Glock, c/o HEUKING KÜHN LÜER WOJTEK, Dusseldorf, NW, DEU, 40474

Website

https://www.elanixbiotechnologies.ch

Elanix Biotechnologies AG is a tissue regeneration company. It develops and commercializes products for acute wound care, dermatological and gynecological applications as well as providing cell technology services. The company's operating segment include Regenerative Medicine and Cosmetic ointments. It generates maximum revenue from the Cosmetic ointments segment. Geographically, it derives a majority of revenue from Switzerland and also has a presence in the EU, and Taiwan.

Elanix Biotechnologies AG (FRA:ELN) Headlines

No Headlines